OTCMKTS:SVNTQ - Savient Pharmaceuticals Stock Price, Price Target & More

$0.0019 0.00 (0.00 %)
(As of 04/20/2018 04:00 PM ET)
Previous Close$0.0019
Today's RangeN/A
52-Week RangeN/A
Average Volume340,036 shs
Market Capitalization$139,409.00
P/E RatioN/A
Dividend YieldN/A

About Savient Pharmaceuticals (OTCMKTS:SVNTQ)

Savient Pharmaceuticals logoSavient Pharmaceuticals, Inc. (Savient), incorporated in 1980, is a specialty biopharmaceutical company focused on commercializing KRYSTEXXA (pegloticase) in the United States and completing the development and seeking regulatory approval outside of the United States for KRYSTEXXA, particularly in the European Union. The Company also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. In October 2013, the Company announced that it has elected to file voluntary petitions under Chapter 11 of the Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware (the Court). Effective January 10, 2014, Crealta Pharmaceuticals LLC, a majority owned unit of GTCR LLC acquired Savient Pharmaceuticals Inc.

Receive SVNTQ News and Ratings via Email

Sign-up to receive the latest news and ratings for SVNTQ and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A


Outstanding Shares73,370,000

How to Become a New Pot Stock Millionaire

Savient Pharmaceuticals (OTCMKTS:SVNTQ) Frequently Asked Questions

What is Savient Pharmaceuticals' stock symbol?

Savient Pharmaceuticals trades on the OTCMKTS under the ticker symbol "SVNTQ."

Who are some of Savient Pharmaceuticals' key competitors?

Has Savient Pharmaceuticals been receiving favorable news coverage?

Media stories about SVNTQ stock have trended somewhat positive on Saturday, according to Accern Sentiment. The research firm ranks the sentiment of news coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Savient Pharmaceuticals earned a news impact score of 0.10 on Accern's scale. They also assigned news articles about the biopharmaceutical company an impact score of 45.31 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the near future.

How do I buy shares of Savient Pharmaceuticals?

Shares of SVNTQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Savient Pharmaceuticals' stock price today?

One share of SVNTQ stock can currently be purchased for approximately $0.0019.

How big of a company is Savient Pharmaceuticals?

Savient Pharmaceuticals has a market capitalization of $139,409.00.

How can I contact Savient Pharmaceuticals?

Savient Pharmaceuticals' mailing address is 1 Tower Center Blvd, EAST BRUNSWICK, NJ 08816-1145, United States. The biopharmaceutical company can be reached via phone at +1-732-4189300.

MarketBeat Community Rating for Savient Pharmaceuticals (SVNTQ)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  58 (Vote Outperform)
Underperform Votes:  87 (Vote Underperform)
Total Votes:  145
MarketBeat's community ratings are surveys of what our community members think about Savient Pharmaceuticals and other stocks. Vote "Outperform" if you believe SVNTQ will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SVNTQ will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Savient Pharmaceuticals (OTCMKTS:SVNTQ) Analyst Ratings History

DateBrokerageActionRatingPrice TargetDetails
(Data available from 4/21/2016 forward)


Savient Pharmaceuticals (OTCMKTS:SVNTQ) Earnings History and Estimates Chart

Earnings by Quarter for Savient Pharmaceuticals (OTCMKTS:SVNTQ)

Savient Pharmaceuticals (OTCMKTS SVNTQ) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/14/2013Q3 2013($0.28)$6.57 millionViewN/AView Earnings Details
8/14/2013Q2 2013($0.31)($0.35)$5.84 million$6.10 millionViewN/AView Earnings Details
5/15/2013Q1 2013($0.31)($0.34)$5.65 million$4.70 millionViewN/AView Earnings Details
3/19/2013Q4 2012($0.44)($0.39)$6.18 million$4.95 millionViewN/AView Earnings Details
11/8/2012Q312($0.45)($0.56)$5.87 million$4.91 millionViewN/AView Earnings Details
8/8/2012($0.45)($0.23)ViewN/AView Earnings Details
5/9/2012($0.49)($0.49)ViewN/AView Earnings Details
2/27/2012Q4 2011($0.40)($0.44)ViewN/AView Earnings Details
11/3/2011($0.38)($0.39)ViewN/AView Earnings Details
8/4/2011($0.28)($0.43)ViewN/AView Earnings Details
5/5/2011($0.31)($0.19)ViewN/AView Earnings Details
2/25/2011($0.26)$0.01ViewN/AView Earnings Details
11/4/2010Q3 2010($0.20)($0.24)ViewN/AView Earnings Details
8/3/2010Q2 2010($0.21)($0.17)ViewN/AView Earnings Details
5/5/2010Q1 2010($0.24)($0.16)ViewN/AView Earnings Details
2/25/2010Q4 2009($0.29)($0.19)ViewN/AView Earnings Details
11/4/2009Q3 2009($0.31)($0.42)ViewN/AView Earnings Details
8/10/2009Q2 2009($0.38)($0.32)ViewN/AView Earnings Details
5/6/2009Q1 2009($0.37)($0.41)ViewN/AView Earnings Details
2/25/2009Q4 2008($0.33)($0.45)ViewN/AView Earnings Details
11/5/2008Q3 2008($0.39)($0.32)ViewN/AView Earnings Details
8/6/2008Q2 2008($0.35)($0.45)ViewN/AView Earnings Details
5/7/2008Q1 2008($0.32)($0.33)ViewN/AView Earnings Details
3/11/2008Q4 2007($0.27)($0.32)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


Savient Pharmaceuticals (OTCMKTS:SVNTQ) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Savient Pharmaceuticals (OTCMKTS SVNTQ) Insider Trading and Institutional Ownership History

Insider Trading History for Savient Pharmaceuticals (OTCMKTS:SVNTQ)

Savient Pharmaceuticals (OTCMKTS SVNTQ) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/22/2013Louis FerrariCEOSell1,020$0.57$581.40View SEC Filing  
2/4/2013Louis FerrariCEOSell62,200$1.01$62,822.00View SEC Filing  
2/4/2013Philip K YachmetzSVPSell30,500$1.01$30,805.00View SEC Filing  
2/4/2013Richard CrowleyEVPSell48,900$1.03$50,367.00View SEC Filing  
(Data available from 1/1/2013 forward)


Savient Pharmaceuticals (OTCMKTS SVNTQ) News Headlines

No headlines for this company have been tracked by MarketBeat.com

SEC Filings

Savient Pharmaceuticals (OTCMKTS:SVNTQ) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Savient Pharmaceuticals (OTCMKTS:SVNTQ) Income Statement, Balance Sheet and Cash Flow Statement


Savient Pharmaceuticals (OTCMKTS SVNTQ) Stock Chart for Saturday, April, 21, 2018

Loading chart…

This page was last updated on 4/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.